May 24, 2022

Volume XII, Number 144

Advertisement

Bryan P. Murray

Bryan focuses his practice on health care law and provides legal counsel to health care industry clients on a range of issues, such as specialty and mail-order pharmacy operations, provider networks and reimbursement, regulatory compliance, contract review and preparation and 340B programming. He has experience analyzing pharmaceutical trade issues affected by state and federal regulatory frameworks, including pharmacy practice acts, the anti-Kickback Statute, the Drug Supply Chain Security Act, the Stark Law and the Health Insurance Probability and Accountability Act. Bryan also develops and implements compliance plans tailored to detect and address instances of non-compliance in areas, including health information privacy, pharmacy dispensing, and fraud, waste and abuse.

Advertisement

Articles in the National Law Review database by Bryan P. Murray

Pages

The National Law Review selected Bryan P. Murray of Dinsmore & Shohl as a Go To Thought Leader for his coverage of 340B Drug Pricing. Mr. Murray’s extensive analysis included U.S. HRS 340B COVID-19 resources and regulations, 340B civil penalties, Health and Human Services (HHS) regulatory rules, and more. NLR readers appreciate Mr. Murray’s comprehensive coverage of the topic, making him a go-to source for the latest news on 340B drug pricing.  

 

Advertisement
Advertisement
Advertisement
Advertisement